Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Age-Adjusted D-Dimer Cut-Off Levels to Rule-out Venous Thromboembolism in Patients with Non-High Pre-Test Probability. Clinical Performance and Cost-Effectiveness Analysis

Pierre A. Toulon, MD PhD, Neila De Pooter, MD, Marie Brionne-François, MD, Motalib Smahi, MD, Lien Abecassis, MD

Blood (2016) 128 (22): 4729.

https://doi.org/10.1182/blood.V128.22.4729.4729

Published: 2016

Journal Articles

Detection of Mild Clotting Factor Deficiencies. Critical Role of the Activated Partial Thromboplastin Time (aPTT) Reagent

Pierre A. Toulon, Yaelle Eloit, Motalib Smahi, Didier Jambou, Anny Appert-Flory, Florence Fischer

Blood (2015) 126 (23): 3281.

https://doi.org/10.1182/blood.V126.23.3281.3281

Published: 2015

Journal Articles

Age Dependency Of Coagulation Parameters During Childhood

Pierre A. Toulon, MD, PhD, Julien Arcizet, MD, François Grand, MD, Neila De Pooter, MD, Dominique Lasnes, MD, PhD, Marie Brionne-François, MD

Blood (2013) 122 (21): 2341.

https://doi.org/10.1182/blood.V122.21.2341.2341

Published: 2013

Journal Articles

Performance of Age-Adjusted D-Dimer Cut-off Values to Rule Out Venous Thromboembolism in Patients with Non-High Pre-Test Probability

Pierre A. Toulon, MD, PhD, Yann-Erick Claessens, MD, PhD

Blood (2012) 120 (21): 1147.

https://doi.org/10.1182/blood.V120.21.1147.1147

Published: 2012

Journal Articles

Economic Impact of a Screening Strategy for Protein C Pathway Abnormalities Based on a New Global Chromogenic Assay (HemosIL ThromboPath) as a First Step Screening Assay In a Series of 597 Unselected Consecutive Patients.

Pierre A. Toulon, MD, PhD, Isabelle Martin-Toutain, MD, Annick Ankri, MD

Blood (2010) 116 (21): 3822.

https://doi.org/10.1182/blood.V116.21.3822.3822

Published: 2010

Journal Articles

Monitoring Treatments with Unfractionated Heparin: CTAD Must Be Used Instead of Citrate as the Anticoagulant Solution When Using Partial-Draw Collection Tubes.

Pierre A. Toulon, MD, PhD, Lién Abecassis, MD, Motalib Smahi, MD, Catherine Ternisien, MD

Blood (2009) 114 (22): 2091.

https://doi.org/10.1182/blood.V114.22.2091.2091

Published: 2009

Journal Articles

Heparin Cofactor II (HCII) Levels and the Risk of Ischemic Stroke. No Deleterious Role of HCII Deficiency but Potential Protective Role of High Plasma Level

Pierre A. Toulon, Mathieu Zuber, Raphael Adda, Jean-Louis Mas

Blood (2008) 112 (11): 5344.

https://doi.org/10.1182/blood.V112.11.5344.5344

Published: 2008

Journal Articles

Performance of a New Global Chromogenic Assay for Protein C Pathway (HemosIL ThromboPath) in the Diagnosis of Lupus Anticoagulant and Antiphospholipid Antibodies.

Pierre A. Toulon, Isabelle Martin-Toutain, Jean-Charles Piette, Marie-Claude Diemert, Annick Ankri

Blood (2008) 112 (11): 2279.

https://doi.org/10.1182/blood.V112.11.2279.2279

Published: 2008

Journal Articles

A New Chromogenic Assay (HemosIL ThromboPath) Is Sensitive to Major Prothrombotic Risk Factors Affecting the Protein C Pathway. Results of a Multicenter Study.

Pierre A. Toulon, Mikhail Smirnov, Mark Triscott, Armando Tripodi

Blood (2007) 110 (11): 1626.

https://doi.org/10.1182/blood.V110.11.1626.1626

Published: 2007

Journal Articles

Sensitivity of a New Global Assay for Protein C (PC) Pathway Abnormalities and Potential Significance of an Abnormal Test Result as a Risk Factor/Marker for Thrombosis Independently of Its Sensitivity for PC Pathway Abnormalities.

Pierre A. Toulon, Nadia Rosencher, Aurélie Guigon, Arnaud Simon

Blood (2005) 106 (11): 2635.

https://doi.org/10.1182/blood.V106.11.2635.2635

Published: 2005

Journal Articles

Monitoring of Coagulation during Hemorrhagic Surgery by Central Laboratory and Near-Patient Testing. Results of a Multicenter Study.

Pierre A. Toulon, Yves Ozier, Annick Ankri, Marie-Helene Fleron, Genevieve Leroux, Marc Samama

Blood (2004) 104 (11): 1043.

https://doi.org/10.1182/blood.V104.11.1043.1043

Published: 2004

Journal Articles

Usefulness of a New Polymer Sampling Tube for Coagulation Testing in Untreated Patients and in Patients on Traditional Anticoagulant Therapy. Results of a Multicentre Evaluation.

Pierre A. Toulon, Marie-Francoise Aillaud, Dominique Arnoux, Benedicte Delahousse, Celine Gourmel

Blood (2004) 104 (11): 3974.

https://doi.org/10.1182/blood.V104.11.3974.3974

Published: 2004

NARROW

Age-Adjusted D-Dimer Cut-Off Levels to Rule-out Venous Thromboembolism in Patients with Non-High Pre-Test Probability. Clinical Performance and Cost-Effectiveness Analysis

Detection of Mild Clotting Factor Deficiencies. Critical Role of the Activated Partial Thromboplastin Time (aPTT) Reagent

Age Dependency Of Coagulation Parameters During Childhood

Performance of Age-Adjusted D-Dimer Cut-off Values to Rule Out Venous Thromboembolism in Patients with Non-High Pre-Test Probability

Economic Impact of a Screening Strategy for Protein C Pathway Abnormalities Based on a New Global Chromogenic Assay (HemosIL ThromboPath) as a First Step Screening Assay In a Series of 597 Unselected Consecutive Patients.

Monitoring Treatments with Unfractionated Heparin: CTAD Must Be Used Instead of Citrate as the Anticoagulant Solution When Using Partial-Draw Collection Tubes.

Heparin Cofactor II (HCII) Levels and the Risk of Ischemic Stroke. No Deleterious Role of HCII Deficiency but Potential Protective Role of High Plasma Level

Performance of a New Global Chromogenic Assay for Protein C Pathway (HemosIL ThromboPath) in the Diagnosis of Lupus Anticoagulant and Antiphospholipid Antibodies.

A New Chromogenic Assay (HemosIL ThromboPath) Is Sensitive to Major Prothrombotic Risk Factors Affecting the Protein C Pathway. Results of a Multicenter Study.

Sensitivity of a New Global Assay for Protein C (PC) Pathway Abnormalities and Potential Significance of an Abnormal Test Result as a Risk Factor/Marker for Thrombosis Independently of Its Sensitivity for PC Pathway Abnormalities.

Monitoring of Coagulation during Hemorrhagic Surgery by Central Laboratory and Near-Patient Testing. Results of a Multicenter Study.

Usefulness of a New Polymer Sampling Tube for Coagulation Testing in Untreated Patients and in Patients on Traditional Anticoagulant Therapy. Results of a Multicentre Evaluation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only